Inovio Pharmaceuticals Inc (INO)
9.09
-0.36
(-3.81%)
USD |
NASDAQ |
Jun 14, 16:00
9.11
+0.02
(+0.22%)
After-Hours: 20:00
Inovio Pharmaceuticals Revenue (Annual): 0.832M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.832M |
| December 31, 2022 | 10.26M |
| December 31, 2021 | 1.775M |
| December 31, 2020 | 7.411M |
| December 31, 2019 | 4.112M |
| December 31, 2018 | 30.48M |
| December 31, 2017 | 42.22M |
| December 31, 2016 | 35.37M |
| December 31, 2015 | 40.57M |
| December 31, 2014 | 10.46M |
| December 31, 2013 | 13.47M |
| December 31, 2012 | 4.119M |
| December 31, 2011 | 9.795M |
| Date | Value |
|---|---|
| December 31, 2010 | 6.145M |
| December 31, 2009 | 9.120M |
| December 31, 2008 | 2.098M |
| December 31, 2007 | 4.808M |
| December 31, 2006 | 3.468M |
| December 31, 2005 | 5.467M |
| December 31, 2004 | 1.167M |
| December 31, 2003 | 0.0805M |
| December 31, 2002 | 0.1895M |
| December 31, 2001 | 0.1106M |
| March 31, 2001 | 4.291M |
| March 31, 2000 | 5.077M |
| March 31, 1999 | 8.321M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.832M
Minimum
2023
10.26M
Maximum
2022
4.878M
Average
4.112M
Median
2019
Revenue (Annual) Benchmarks
| Novavax Inc | 556.38M |
| Sangamo Therapeutics Inc | 176.23M |
| Stereotaxis Inc | 26.77M |
| Vaxart Inc | 7.379M |
| Capricor Therapeutics Inc | 25.18M |